glp 1 blue cross blue shield GLP-1 Drugs Could Raise Employer Health Premiums Ro launches the GLP-1 Insurance

Truveta and collaborators partnered on a new large-scale study that considers the potential benefits of GLP-1 RA for AUD, among those with diabetes and/or obesity

In an MDL case, each plaintiff retains their own individual claim

What About Diabetic Retinopathy

However, several key points matter for patients and clinicians: Hair loss has been reported with other GLP-1based weight loss drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro)

The S&P 500's 3 Best-Performing Stocks So Far in 2026 Last quarter, the company submitted its drug orforglipron, a new GLP-1 agonist, for obesity treatment in the United States and more than three dozen additional countries, with an expected domestic launch by mid-2026